Optibet
Optibet Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Optibet is a brand name. Its generic name is Betaxolol.
Optibet
Optibet is a medication in the class of cardio-selective beta-blockers used in the treatment of hypertension, angina, tachyarrhythmias, and glaucoma. Used orally and topically, Optibet is a drug widely prescribed to treat certain heart conditions.Uses For
Optibet is primarily used in the treatment of hypertension by blocking the beta receptors in the body. Additionally, Optibet is also used to treat arrhythmias, angina, and glaucoma. By decreasing the heart rate and cardiac contractility, it helps to reduce blood pressure and prevent heart attacks.Mechanism of Action
Optibet works by decreasing the number of beta receptors in the body, thus reducing the activity of the heart, resulting in a slower heart rate. Optibet also inhibits the hormone adrenaline from binding to these beta receptors, further reducing the activity of the heart.How Long Does it Take to Work?
The effects of Optibet start to take effect within 20 minutes of administration and should reach peak effect within an hour after ingestion.Absorption
Optibet is rapidly absorbed after the oral administration. Its bioavailability is more than 90%.Route of Elimination
Optibet is eliminated primarily in the urine.Dosage
For hypertension, the initial dose is 5mg two times a day. The dosage may be increased up to 40mg two times a day, depending on the patient’s response. For arrhythmias, the initial dose is 5mg two times a day. The dosage may be increased up to 20mg two times a day, depending on the patient’s response. For glaucoma, the initial dose is 2.5mg two times a day. The dosage may be increased up to 20mg two times a day, depending on the patient’s response.Administration
Optibet can be taken orally or administered as an ophthalmic solution.Side Effect
The most common side effects associated with Optibet include dizziness, headaches, lethargy, nausea, and cold hands and feet.Toxicity
Optibet is generally well tolerated. Overdose of Optibet can cause undesired bradycardia, hypotension, and congestive heart failure.Precaution
Patients should inform the health care provider of any pre-existing conditions before taking Optibet, such as diabetes, heart failure, kidney disease, or liver disease. Chronic use of Optibet can lead to drug tolerance, so it should be used with caution. Optibet can also interact with other medications, so patients should ensure to inform the health care provider of all medications they are taking before taking Optibet.Interaction
Patients should inform the health care provider of all medications they are taking before taking Optibet. Optibet may interact with certain medications and supplements to produce undesired effects. Patients with any pre-existing conditions should inform the health care provider of any medications they may be taking.Disease Interaction
Due to its effect on the heart, there is a risk of adverse reactions in patients with underlying heart diseases while taking Optibet. Patients with diabetes, heart failure, or kidney disease should exercise caution while taking Optibet as it can increase the risks associated with the condition.Drug Interaction
Optibet may interact with certain medications like calcium-channel blockers, vasodilators, clonidine, and other beta-blockers. Optibet can also interact with certain supplements like omega-3 fatty acids, St. John’s Wort, Ginkgo biloba, and other products.Food Interactions
Optibet should not be taken with food. Food can reduce the absorption of Optibet and may increase the risk of adverse reactions.Pregnancy Use
The safety of Optibet during pregnancy has not been established. It is advised that pregnant women should consult a healthcare provider before taking Optibet.Lactation Use
It is not recommended to take Optibet while breastfeeding as it can pass into the breast milk and affect the baby.Acute Overdose
Overdose of Optibet can lead to unwanted symptoms such as bradycardia, hypotension, and congestive heart failure. In case of an overdose, the patient should seek immediate medical attention.Contraindication
Optibet is contraindicated in patients with severe bradycardia, heart block, sick sinus syndrome, and bronchial asthma.Use Direction
Optibet should be taken as directed by the health care provider. It should be taken with or without food, depending on the prescriber's instructions. The administration of Optibet may be modified according to the patient's response, and the dosage should not be altered without consulting with the healthcare provider.storage Condition
Optibet should be stored at room temperature, away from light and moisture.Volume of Distribution
Optibet has a wide distribution in the body. It is rapidly absorbed after the oral administration with more than 90% bioavailability.Half Life
The half-life of Optibet is approximately 4-9 hours.Clearance
The clearance of Optibet is 500-1,280 mL/min.Here you find in details version of Optibet
Some Frequently Asked Questions About Optibet
https://www.medicinesfaq.com/brand/optibet,
http://classyfire.wishartlab.com/tax_nodes/C0000000,
http://classyfire.wishartlab.com/tax_nodes/C0002448,
http://classyfire.wishartlab.com/tax_nodes/C0000134,
http://classyfire.wishartlab.com/tax_nodes/C0000139,
http://classyfire.wishartlab.com/tax_nodes/C0000139,
http://classyfire.wishartlab.com/tax_nodes/C0004742,
http://classyfire.wishartlab.com/tax_nodes/C0002341,
http://classyfire.wishartlab.com/tax_nodes/C0000128,
http://classyfire.wishartlab.com/tax_nodes/C0001661,
http://classyfire.wishartlab.com/tax_nodes/C0001897,
http://classyfire.wishartlab.com/tax_nodes/C0002228,
http://classyfire.wishartlab.com/tax_nodes/C0001167,
http://classyfire.wishartlab.com/tax_nodes/C0004557,
http://classyfire.wishartlab.com/tax_nodes/C0004150,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3082,
http://www.hmdb.ca/metabolites/HMDB0014341,
http://www.genome.jp/dbget-bin/www_bget?cpd:C06849,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2369,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506041,
https://www.chemspider.com/Chemical-Structure.2279.html,
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50405521,
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1520,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=3082,
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL423,
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000305,
http://www.pharmgkb.org/drug/PA448611,
http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=549,
http://www.rxlist.com/cgi/generic3/betaxolol.htm,
https://www.drugs.com/cdi/betaxolol-drops.html,
https://en.wikipedia.org/wiki/Betaxolol,